Baxter (NYSE:BAX) announced today that data shows the potential for machine learning supporting decision-making with infusion pump programming.
Deerfield, Illinois-based Baxter presented the data from a retrospective study — part of a collaboration with MedAware aimed to develop next-generation dose error reduction software — at the American Society of Health-System Pharmacists (ASHP) 2021 Midyear Clinical Meeting.
Get the full story at our sister site, Drug Delivery Business News.